Genoscience Pharma receives orphan drug designation for hepatocellular carcinoma drug
Genoscience Pharma has announced that its lead candidate, ezurpimtrostat, a PPT-1 (Palmitoyl Protein Thioesterase-1) inhibitor,…
February 3, 2023 - 3 minutes
Clinical trial
Almost 20% of cancer trials have recruited only one patient
Phesi Inc., a global provider of clinical development data analytics, has published an analysis of…
February 2, 2023 - 3 minutes
Expanding the world of biomarkers with proteogenomics
By Michael Pisano, executive vice president, proteomics, Discovery Life Sciences In oncology, characterizing genetic markers…
February 1, 2023 - 7 minutes
Active Biotech trial confirms eye treatment safety
Active Biotech has announced the completion of the phase I clinical study testing the safety…
January 31, 2023 - 3 minutes
BiVictriX announces positive data from leukemia study
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with…
January 31, 2023 - 3 minutes
Psoriasis drug may help treat type 1 diabetes
A large clinical study is now beginning on an approved drug for treating psoriasis. The…
January 27, 2023 - 5 minutes
Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of…
January 27, 2023 - 4 minutes
FDA clearance for ‘revolutionary’ approach to J-Pouch issue
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
January 27, 2023 - 2 minutes
Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
January 26, 2023 - 3 minutes
Sponsored
by LINK Medical
How clinical trials benefit from decentralized solutions: A Nordic case study
Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical…
January 26, 2023 - 6 minutes
First patient treated in Atrogi type 2 diabetes clinical study
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
January 26, 2023 - 2 minutes
First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
January 24, 2023 - 2 minutes
